资讯 | 疫情影响美股,连续二日下跌,A 股 5G 股恒强。

资讯摘要
美股周二连续第二日暴跌,道指两日共狂泻逾1900点。多家企业预警称疫情将影响其业绩。美国10年期国债收益率创历史新低。美国疾控中心警告说美国人应该为病毒传播到自己的社区做好防备。
 
美股资讯
北京时间2月26日凌晨,美股周二连续第二日暴跌,道指两日共狂泻逾1900点。多家企业预警称疫情将影响其业绩。美国10年期国债收益率创历史新低。美国疾控中心警告说美国人应该为病毒传播到自己的社区做好防备。截止收盘,道指收盘下跌879.44点,或3.15%,报27081.36点;纳指跌255.67点,或2.77%,报8965.61点;标普500指数跌97.68点,或3.03%,报3128.21点。周一道指创2年来的最大单日跌幅。2018年2月5日,道指收盘暴跌1175点,三日后,该指数再度重挫1033点。

道指周二收盘狂泻约880点,收于200日均线下方,为去年8月15日以来首次。周一收盘暴跌1031点,这是该指数史上首次录得连续两日跌超800点。

周二盘中道指一度下跌逾960点,跌破27000关口,最低下跌至26997.62点。美国10年期国债收益率下降至1.324%,创历史新低。

标普500指数的11大组成板块悉数下挫,能源股和材料股领跌。能源、材料和工业板块均跌超4%,科技股、银行股也集体下跌。

FAANG科技股巨头全线走低。苹果收盘下跌3.39%,亚马逊跌1.82%,奈飞跌2.34%,谷歌跌2.33%,Facebook跌1.97%。

热门中概股多数收跌,阿里巴巴跌0.27%,京东跌1.35%,百度跌1.11%;500彩票网跌15.8%,途牛跌6.78%,人人网跌4.37%,搜狗跌4.17%;聚美优品涨26.18%,无忧英语涨14.43%,蔚来汽车涨13.92%,瑞幸咖啡涨3.59%。

虽然特朗普在昨日美股暴跌后发布推文表示冠状病毒在美国得到很好的控制,并鼓励投资者抄底股市,但看来市场和美国疾控中心都不同意他的看法。

世界卫生组织的官员周一表示,疫情尚未出现大流行。世卫组织总干事谭德塞博士在新闻发布会上说:“我们没有目睹这种病毒在全球范围内的蔓延。我们看到的是,世界不同地方出现病毒流行,各国受影响的方式各不相同。”

新型冠状病毒疫情在韩国、伊朗和意大利等多国迅速传播,加剧了市场对全球经济长期放缓的担忧,促使昨日投资者加速逃离股市。

韩国将其冠状病毒警报提高到“最高水平”,截至周二,该国确诊感染病例已增加到977例,死亡11例。

美国知名制药公司Moderna已经成功研制出针对新冠肺炎的人体疫苗,并已将第一批疫苗送至美国国家卫生研究院开启安全性临床试验。预计最快将在4月底进入临床实验阶段。

万事达公司下调季度收入预测。

惠普2020财年第一季度营收146亿美元,宣布150亿美元回购计划。

美国联合航空公司与万事达卡周二警告称,新型冠状病疫情可能对其2020年业绩造成负面冲击。

美国银行将美光科技的股票评级从“持有”下调为“低配”

焦点个股

重型设备销售商Deere(DE)宣布第一财季业绩好于预期,原因是贸易紧张局势缓解之后农民的情绪回升。该公司每股收益1.63美元,销售收入65.3亿美元。去年同期每股收益1.25美元,销售收入62.8亿美元。Deere公司重申全年业绩目标,预计净盈利将在27亿美元至31亿美元之间。

斯普林特(10.05, 0.57, 6.01%)与T-Mobile宣布同意修改合并协议。

特斯拉(901, 1.59, 0.18%)负责人力资源和超级工厂事务的资深高管卡塞克特已于上周离职。特斯拉超级工厂二期列入上海市重大预备项目。

可口可乐(60.13, 0.41, 0.69%)重申全年指引,预计当前环境对收入有1至2个基本点的影响,对第一季度每股盈利有0.01-0.02美元的影响,但仍然相信可以达成全年指引。

摩根大通(135.81, -1.68, -1.22%)和高盛20日发布声明称,支持建立一个新股票交易市场Members Exchange(MEMX),该市场将与纽约证交所和纳斯达克(9576.5901, -174.37, -1.79%)展开竞争。

云存储公司Dropbox四季度总营收为4.46亿美元,同比增长19%,也超出市场预期。

热点中概股
来源:东方财富网、同花顺、新浪财经、腾讯证券、华尔街见闻、辉立证券
 
港股资讯
北京时间2月25日,全球股市大动荡。亚洲疫情严重的韩国股市24日跌幅近4%;欧洲疫情严重的意大利股市暴跌超5%,旅游胜地希腊股市跌幅最大跌幅接近10%,股市几乎全线杀跌;美股道指收报27,960点,跌1,031点或3.56%,创两年来最大单日跌幅,且今年升幅全化灰,累计倒跌2.02%。周二早盘,恒指窄幅震荡。截止收盘,恒指涨0.27%,报26893.23点;红筹指数跌0.36%,国企指数涨0.11%。大市成交1179亿港元。热点板块

黄金股集体回调,山东黄金跌6.54%,紫金矿业跌4.68%,招金矿业、恒兴矿业等跌逾3%。

特斯拉概念股今日反弹,其中,赣锋锂业涨9.78%,舜宇光学涨4.14%,中芯国际涨7.23%,比亚迪股份涨3.79%。

科网股在香港集体走高,腾讯大涨2.87%,小米、美团涨也涨近3%,阿里涨0.68%。据小浪统计wind数据测算,美国5大科技巨头单日市值蒸发2369亿美元,折合1.67万亿人民币。该5间科技巨擘包括苹果公司、Facebook、亚马逊、微软,以及Alphabet,合共已经佔标普500指数总市值的近5分之1。

融创中国预期净利大增逾50%,今日股价涨2.06%,报价42.45港元。融创中国昨晚发布正面盈利预告称,预期2019年度公司拥有人应占溢利较上年度增长超过50%,主要原因是2019年度物业销售交付的面积较上年度增加。

在线教育股再度走高,新东方在线涨6.85%,报价35.3港元,最新市值331亿港元,2月以来涨30%,今年以来暴涨90%。北水不断加仓,最新持股占比为14.75%。广东省教育厅下发《关于线上教育安排的通知》,明确全省中小学校3月2日起开展线上教育,学生不返校。学生返校时间,将视疫情防控情况,经科学研判后确定,提前向社会发布。

全天涨幅最大的5支港股通
来源:东方财富网、同花顺、新浪财经、腾讯证券、华尔街见闻、辉立证券
 
中国A股资讯
北京时间2月25日,受海外股市大跌影响,三大股指集体低开。随后,沪指震荡走强再度站回3000点上方,创指几经波折,盘中二度翻红再度走强。临近上午收盘,市场风云突变,三大股指迅速走弱,创指跌幅一度超过4%,沪指、深成指跌幅也相继扩大。短暂探底后三大股指又迅速反弹,沪深两市半日成交超过9000亿元。午后指数持续走强,创指上演深V反转翻红,早盘跌超4%。早盘的恐慌情绪得到持续释放,炸板率较低,市场逐渐企稳。尾盘,沪指跌幅再度收窄,深成指拉升翻红,创指涨幅一度超1.2%,再创反弹新高。盘面上,5G、半导体等科技题材大幅走强,市场做多情绪也再度高涨。截止收盘,沪深两市成交额达1.42万亿,为2015年11月以来新高,也连续5日保持在万亿之上。深市成交额超过9000亿。沪指报3013.05点,跌0.60%,成交额为5131亿元;深成指报11856.08点,涨0.71%,成交额为9022亿元。从盘面上看,口罩、通信、智能汽车居板块涨幅榜前列,采掘、电竞、转基因板块跌幅榜前列。

热门板块

口罩板块走高,搜于特、华升股份、道恩股份、延江股份、泰达股份、振德医药、欣龙控股南卫股份等多股走高。

消息面上近日,日本和韩国新冠病毒感染确诊病例数继续攀升,其中韩国确诊病例增加较多。日前,韩国政府已将新冠肺炎疫情预警上调至最高的“严重”级别。此外,意大利、伊朗等国家新增病例也有所增加。

5G板块恒强,中兴通讯、沪电股份、宜通世纪、露笑科技、海特高新、永鼎股份等多股表现强势。

消息面上新冠肺炎疫情蔓延,全民持续战“疫”。在本次疫情防控中,5G所实现的智能医疗频频发挥作用,以5G为代表的通信新技术更是为防疫提供了有力的支持,其中包括智能医疗、大数据、云产业等应用表现均十分亮眼。

全天涨幅最大的5支沪港通

来源:东方财富网、同花顺、新浪财经、腾讯证券、华尔街见闻、辉立证券

联系我们开设账户

需要帮助吗?请分享您的详细资料,我们会给您答复。

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com